Literature DB >> 10206288

Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG).

W Sauerbrei1, P Royston, H Bojar, C Schmoor, M Schumacher.   

Abstract

Prognostic models that predict the clinical course of a breast cancer patient are important in oncology. We propose an approach to constructing such models based on fractional polynomials in which useful transformations of the continuous factors are determined. The idea may be applied with all types of regression model, including Cox regression, the method of choice for survival-time data. We analyse a prospective study of node-positive breast cancer. Seven standard prognostic factors--age, menopausal status, tumour size, tumour grade, number of positive lymph nodes, progesterone and oestrogen receptor concentrations--were investigated in 686 patients, of whom 299 had an event for recurrence-free survival and 171 died. We determine a final model with transformations of prognostic factors and compare it with the more traditional approaches using categorized variables or assuming a straight line relationship. We conclude that analysis using fractional polynomials can extract important prognostic information which the traditional approaches may miss.

Entities:  

Mesh:

Year:  1999        PMID: 10206288      PMCID: PMC2362813          DOI: 10.1038/sj.bjc.6690279

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Validation of existing and development of new prognostic classification schemes in node negative breast cancer. German Breast Cancer Study Group.

Authors:  W Sauerbrei; K Hübner; C Schmoor; M Schumacher
Journal:  Breast Cancer Res Treat       Date:  1997-01       Impact factor: 4.872

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 3.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

Authors:  D G Altman; B Lausen; W Sauerbrei; M Schumacher
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

4.  The prognostic effect of histological tumor grade in node-negative breast cancer patients.

Authors:  M Schumacher; C Schmoor; W Sauerbrei; A Schauer; L Ummenhofer; W Gatzemeier; H Rauschecker
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Consideration of covariates and stratification in sample size determination for survival time studies.

Authors:  M Palta; S B Amini
Journal:  J Chronic Dis       Date:  1985

6.  Age does not predict breast cancer outcome.

Authors:  J P Crowe; N H Gordon; R R Shenk; R M Zollinger; D J Brumberg; J M Shuck
Journal:  Arch Surg       Date:  1994-05

7.  Age as prognostic factor in premenopausal breast carcinoma.

Authors:  A de la Rochefordiere; B Asselain; F Campana; S M Scholl; J Fenton; J R Vilcoq; J C Durand; P Pouillart; H Magdelenat; A Fourquet
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

8.  Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group.

Authors:  M Schumacher; G Bastert; H Bojar; K Hübner; M Olschewski; W Sauerbrei; C Schmoor; C Beyerle; R L Neumann; H F Rauschecker
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

9.  The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  I Balslev; C K Axelsson; K Zedeler; B B Rasmussen; B Carstensen; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 10.  Statistical aspects of prognostic factor studies in oncology.

Authors:  R Simon; D G Altman
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  22 in total

1.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

2.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

3.  Modeling the effect of tumor size in early breast cancer.

Authors:  Claire Verschraegen; Vincent Vinh-Hung; Gábor Cserni; Richard Gordon; Melanie E Royce; Georges Vlastos; Patricia Tai; Guy Storme
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

4.  Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Authors:  Hassan A Hatoum; Faek R Jamali; Nagi S El-Saghir; Khaled M Musallam; Muhieddine Seoud; Hani Dimassi; Jaber Abbas; Mohamad Khalife; Fouad I Boulos; Ayman N Tawil; Fadi B Geara; Ziad Salem; Achraf A Shamseddine; Karine Al-Feghali; Ali I Shamseddine
Journal:  Indian J Surg Oncol       Date:  2010-08-07

5.  A flexible and robust method for assessing conditional association and conditional concordance.

Authors:  Xiangyu Liu; Jing Ning; Yu Cheng; Xuelin Huang; Ruosha Li
Journal:  Stat Med       Date:  2019-05-09       Impact factor: 2.373

6.  Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Authors:  Hassan A Hatoum; Faek R Jamali; Nagi S El-Saghir; Khaled M Musallam; Muhieddine Seoud; Hani Dimassi; Jaber Abbas; Mohamad Khalife; Fouad I Boulos; Ayman N Tawil; Fadi B Geara; Ziad Salem; Achraf A Shamseddine; Karine Al-Feghali; Ali I Shamseddine
Journal:  Indian J Surg Oncol       Date:  2011-03-29

7.  Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future.

Authors:  R D Riley; K R Abrams; A J Sutton; P C Lambert; D R Jones; D Heney; S A Burchill
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

8.  Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.

Authors:  H E Campbell; A M Gray; A L Harris; A H Briggs; M A Taylor
Journal:  Br J Cancer       Date:  2010-09-07       Impact factor: 7.640

9.  No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial.

Authors:  U Nur; B Rachet; M K B Parmar; M R Sydes; N Cooper; C Lepage; J M A Northover; R James; M P Coleman
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

10.  Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study.

Authors:  Andrea Marshall; Douglas G Altman; Patrick Royston; Roger L Holder
Journal:  BMC Med Res Methodol       Date:  2010-01-19       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.